A Study to Evaluate the Efficacy and Safety of Gefapixant (MK-7264) in Women With Endometriosis-Related Pain (MK-7264-034)

PHASE2CompletedINTERVENTIONAL
Enrollment

187

Participants

Timeline

Start Date

September 11, 2018

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Endometriosis-related Pain
Interventions
DRUG

Gefapixant

Gefapixant tablet 45 mg taken orally

DRUG

Placebo

Placebo matching gefapixant tablet taken orally

DRUG

Naproxen

Naproxen sodium 275 mg tablets taken orally as needed, at dose prescribed by sites' principal investigator

Trial Locations (78)

2010

Holdsworth House Medical Practice ( Site 0009), Sydney

2031

Royal Hospital for Women ( Site 0008), Randwick

2259

Paratus Clinical Kanwal ( Site 0004), Kanwal

5000

Royal Adelaide Hospital ( Site 0007), Adelaide

6009

Keogh Institute for Medical Research ( Site 0002), Nedlands

8013

Southern Clinical Trials Ltd ( Site 0201), Christchurch

20190

PI-Coor Clinical Research, LLC ( Site 0710), Reston

23225

Clinical Research Partners, LLC. ( Site 0704), Richmond

27713

Carolina Women's Research and Wellness Center ( Site 0715), Durham

28023

Hospital Sanitas La Zarzuela ( Site 0502), Aravaca

28050

Hospital Sanitas La Moraleja ( Site 0504), Madrid

29485

Palmetto Clinical Research ( Site 0707), Summerville

33014

Inpatient Research Clinic, LLC ( Site 0725), Miami Lakes

33143

Well Pharma Medical Research, Corp. ( Site 0703), Miami

QPS Miami Research Associates ( Site 0735), South Miami

33144

L&C Professional Medical Research Institute ( Site 0709), Miami

33166

Doral Medical Research, LLC ( Site 0706), Doral

33172

Lenus Research & Medical Group Llc ( Site 0702), Sweetwater

33189

Advanced Pharma Research ( Site 0719), Cutler Bay

33316

KO Clinical Research, LLC ( Site 0723), Fort Lauderdale

33465

New Horizon Research Center ( Site 0717), Miami

33759

Florida Fertility Institute ( Site 0737), Clearwater

35218

Cahaba Medical Care ( Site 0750), Birmingham

37404

Chattanooga Medical Research ( Site 0743), Chattanooga

46400

Communal not commercial institution. Ternopil City Community Hospital 2 ( Site 0903), Ternopil

65023

Multiprofile medical center on the base of Odessa National Medical University ( Site 0908), Odesa

69065

Communal Nonprofit Enterprize Maternity Hospital 4 ( Site 0904), Zaporizhzhya

69071

Communal Institution Maternity Hospital 3 ( Site 0909), Zaporizhzhya

Municipal Institution Zaporizhzhya Regional Clinical Hospital ( Site 0906), Zaporizhzhya

70001

Southern Clinical Research Associates ( Site 0701), Metairie

72205

Lynn Institute of the Ozarks ( Site 0720), Little Rock

76018

Iv-Fr Reg Perinatal center State higher Educa inst Iv-Fr Nat Med University ( Site 0910), Ivano-Frankivsk

77024

HD Research Corp ( Site 0738), Houston

78412

Corpus Christi Clinic ( Site 0744), Corpus Christi

78705

Women Partners in Health ( Site 0745), Austin

85224

Synexus US Phoenix Southeast ( Site 0729), Chandler

85251

Synexus ( Site 0734), Scottsdale

91007

California Center for Clinical Research ( Site 0741), Arcadia

92103

Artemis Institute for Clinical Research ( Site 0716), San Diego

93065

Alta California Medical Group ( Site 0721), Simi Valley

98105

Seattle Women's: Health, Research, Gynecology ( Site 0714), Seattle

101000

Moscow Regional Research Institute of Tocology and Gynecolog ( Site 0411), Moscow

115280

State Institution of Healthcare Moscow City Clinical Hospital 13 ( Site 0408), Moscow

194354

Women clinic 22 ( Site 0400), Saint Petersburg

199034

NII of Obstetrics, Gynecology and Reproductology n.a. D.O. Ott ( Site 0401), Saint Petersburg

214031

Uromed LLC ( Site 0410), Smolensk

420029

Kazan State Medical University ( Site 0404), Kazan'

420033

Clinical Hospital #2 of Kazan city ( Site 0406), Kazan'

420097

LLC Scientific Research Medical Complex Your Health. ( Site 0405), Kazan'

634050

Siberian State Medical University ( Site 0402), Tomsk

1710216

Hospital San Juan de Dios de La Serena ( Site 0110), La Serena

7520440

Clinica Indisa [Santiago, Chile] ( Site 0101), Santiago

7591047

Clinica Las Condes ( Site 0109), Santiago

7650568

Clinica Alemana de Santiago ( Site 0107), Santiago

8360160

Hospital San Borja Arriaran ( Site 0103), Santiago

06340

Thameside OBGYN Center ( Site 0747), Groton

06518

WHUSA Fine and Gillette ( Site 0751), Hamden

02111

Tufts Medical Center ( Site 0742), Boston

0626

Southern Clinical Trials - Waitemata ( Site 0200), Auckland

15-224

Prywatna Klinika Polozniczo - Ginekologiczna ( Site 0300), Bialystok

40-301

Indywidualna Specjalistyczna Praktyka Lekarska Krzysztof Wilk ( Site 0316), Katowice

40-717

SPL Chorob Kobiecych i Połoznictwa dr L. Kobielska ( Site 0339), Katowice

40-750

Clinical Medical Research Sp. z o.o. ( Site 0343), Katowice

40-851

Osrodek Badan Klinicznych Gyncentrum ( Site 0330), Katowice

44-200

LIFTMED ( Site 0325), Rybnik

60-185

Examen Sp. z o.o. ( Site 0318), Skorzewo

02-793

Clinical Best Solutions ( Site 0338), Warsaw

50-547

Marek Elias Gabinety Ginekologiczne ( Site 0331), Wroclaw

00961

Cooperativa de Facultad Medica Sanacoop ( Site 0805), Bayamón

00717-2348

Ponce Health Sciences University ( Site 0804), Ponce

00909

Gynecology & Endometriosis Center LLC ( Site 0806), San Juan

00917

Henry A. Rodriguez-Ginorio Private Practice ( Site 0800), San Juan

00918

Genes Fertility Institute Inc. ( Site 0803), San Juan

03004

Instituto de Ciencias Medicas.ICM ( Site 0500), Alicante

08036

Hospital Clinic i Provincial de Barcelona ( Site 0501), Barcelona

03040

Medical Center Verum ( Site 0900), Kyiv

03067

GI Institute of POG of NAMS of Ukraine ( Site 0905), Kyiv

04112

City Clinical Hospital No. 9 ( Site 0901), Kyiv

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT03654326 - A Study to Evaluate the Efficacy and Safety of Gefapixant (MK-7264) in Women With Endometriosis-Related Pain (MK-7264-034) | Biotech Hunter | Biotech Hunter